A blood test that tracks fragments of DNA shed by dying tumor cells could one day be used to monitor how well patients are responding to cancer treatment, according to a small study in women with advanced breast cancer. Such a test could provide a non-invasive alternative to biopsies, and help adapt treatment to individual patients and the progress of disease.